iPSC Treatment for Diabetic Retinopathy
Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
Recruiting
Observational Study
Diabetes Complications
Diabetic Retinopathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 21 – 98
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20 (estimated)
- Sponsor
- University of Alabama at Birmingham · Other
Who this trial is looking for
This trial is looking for adults aged 21 to 98 who have diabetes or are healthy control participants. Those who join will undergo eye exams and a skin biopsy to help researchers study a new treatment for eye problems caused by diabetes.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 21 and 98 years old.
- I have been diagnosed with diabetes or I am a healthy aged control.
- I can cooperate with the eye exam and skin punch biopsy.
You may not be able to join if
- I have an ongoing acute or chronic infection.
- I have an ongoing cancer.
- I have had a stroke or stroke procedure.
- I am currently pregnant.
- I have had an organ transplant.
- I have a graft.
- I have anemia.
- I have eye problems other than diabetic retinopathy.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This study proposes to carefully examine the hypothesis that human inducible pluripotent stem cells (iPSCs) can be effectively employed as a future therapeutic option for individuals with diabetic retinopathy and macular ischemia. iPSCs will be generated from the peripheral blood cells of subjects with diabetes and age matched controls. The human iPSC cells will be used to generate mesoderm cells …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Any man or woman between the ages of 21- 98 years of age will be eligible to participate. To participate in the study as a study subject we will require: a) the subject must either carry the diagnosis of diabetes or be a healthy aged control and b) the patient be willing and h…
Contacts